HBV REACTIVATION IN HBSAG NEGATIVE PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES POST CHEMOTHERAPY: CASE REPORTS

被引：0
|
作者：
Graziani, F. [1 ]
Esposito, D. [1 ]
De Falco, G. [1 ]
Caparrotti, G. [1 ]
Iovane, E. [1 ]
Pagnini, D. [1 ]
机构：
[1] ASL CE, San Felice A Cancello, CE, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1001
引用
收藏
页码：399 / 399
页数：1
相关论文
共 50 条
  • [41] HBV reactivation can be predicted by combined highly-sensitive HBV markers: implications for an optimized management of HBsAg-negative/anti-HBc-positive oncohematological patients
    Alkhatib, Mohammad
    Salpini, Romina
    Malagnino, Vincenzo
    Cerva, Carlotta
    Piermatteo, Lorenzo
    Battisti, Arianna
    Bertoli, Ada
    Cantonetti, Maria
    Arcese, William
    Silberstein, Francesca Ceccherini
    Perno, Carlo Federico
    Andreoni, Massimo
    Sarmati, Loredana
    Svicher, Valentina
    JOURNAL OF HEPATOLOGY, 2021, 75 : S728 - S728
  • [42] Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
    Liu, Xin
    Chen, Shu-xiang
    Liu, Hui
    Lou, Jin-li
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy
    Tanaka, Yasuhito
    Nakamoto, Daisuke
    Piao, Yi
    Mizutani, Hajime
    Wakabayashi, Ryozo
    Saito, Yoshiyuki
    Kwon, Kyung min
    Dickinson, Harriet
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (07) : 1607 - 1620
  • [44] ImmunosuppressantsBurkitt post-transplant lymphoproliferative disorder: 8 case reports
    Reactions Weekly, 2012, 1431 (1) : 25 - 25
  • [45] ImmunosuppressantsHaemangiosarcoma and post-transplant lymphoproliferative disorder: 4 case reports
    Reactions Weekly, 2011, 1367 (1) : 23 - 24
  • [46] ImmunosuppressantsPlasmacytic post-transplant lymphoproliferative disorder: 9 case reports
    Reactions Weekly, 2015, 1564 (1) : 110 - 111
  • [47] REACTIVATION OF HEPATITIS B VIRUS IN HBSAG NEGATIVE PATIENTS UNDERGOING CHEMOTHERAPY FOR LYMPHOMA AND MULTIPLE MYELOMA: PROSPECTIVE SINGLE-INSTITUTION STUDY
    Matsui, T.
    Kang, J. -H.
    Yane, K.
    Kin, T.
    Shida, H.
    Tsuji, K.
    Maguchi, H.
    Andoh, Seisho
    Andoh, Sachiko
    Sakai, H.
    Maemori, M.
    Tanaka, Y.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S152 - S153
  • [48] HBV reactivation in a HBsAg-negative patient with multiple myeloma treated with prednisolone maintenance therapy after autologous HSCT
    Gu, Ha Ra
    Shin, Dong-Yeop
    Choi, Hong Seok
    Moon, Chae Ho
    Park, Su Cheol
    Kang, Hye Jin
    BLOOD RESEARCH, 2015, 50 (01) : 51 - 53
  • [49] HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis
    Moghoofei, Mohsen
    Mostafaei, Shayan
    Ashraf-Ganjouei, Amir
    Kavosi, Hoda
    Mahmoudi, Mandi
    MICROBIAL PATHOGENESIS, 2018, 114 : 436 - 443
  • [50] EBV reactivation in patients with lymphoproliferative diseases receiving a fludarabine-based regimen.
    Lazzarino, M
    Orlandi, E
    Baldanti, F
    Pagnucco, G
    Astori, C
    Arcaini, L
    Sarasini, A
    Gerna, G
    Bernasconi, C
    BLOOD, 1998, 92 (10) : 623A - 623A
12345